Inhibition of metalloprotease hyperactivity in cystic cholangiocytes halts the development of polycystic liver diseases - Wikidata - wikimedia - TriplyDB

Inhibition of metalloprotease hyperactivity in cystic cholangiocytes halts the development of polycystic liver diseases

Inhibition of metalloprotease hyperactivity in cystic cholangiocytes halts the development of polycystic liver diseases

http://www.wikidata.org/entity/Q35185224

about

Polycystic liver diseases: advanced insights into the molecular mechanisms Mutations in GANAB, Encoding the Glucosidase IIα Subunit, Cause Autosomal-Dominant Polycystic Kidney and Liver Disease Post-translational regulation of the type III inositol 1,4,5-trisphosphate receptor by miRNA-506.Ursodeoxycholic acid inhibits hepatic cystogenesis in experimental models of polycystic liver disease.Therapeutic Targets in Polycystic Liver Disease.Pathobiology of biliary epithelia.Increased MMP-7 expression in biliary epithelium and serum underpins native liver fibrosis after successful portoenterostomy in biliary atresia Serum extracellular vesicles contain protein biomarkers for primary sclerosing cholangitis and cholangiocarcinoma.SOX17 regulates cholangiocyte differentiation and acts as a tumor suppressor in cholangiocarcinoma.Primary cilia disruption differentially affects the infiltrating and resident macrophage compartment in the liver.Elevated interleukin-8 in bile of patients with primary sclerosing cholangitis.

P2860

Q27001174-84505D78-CA12-484E-87AD-94C9857E3E5A Q34529587-F364511B-0DBB-4A25-BAC9-D4A4591E4463 Q34801354-FC2AF0B9-98DA-4DE5-8948-32E7D76D50D3 Q36075389-12326C31-7239-4403-A5B4-5EB86B20C4C5 Q38443908-A79CE046-FE17-407F-A21A-7BF3C5D1143A Q39440062-E4BB087A-E115-4024-9234-4A6DE8C6D876 Q39514189-3473EF30-5731-4225-8EBA-8FE834B5E74F Q48553032-9951AC81-9977-405C-9202-8DDEF2B5E302 Q48821774-B0DE217E-4423-473B-8628-56431814DDBA Q51739818-0DD88F13-8182-4CDD-9D76-A9FBA165661B Q52885250-909F1050-689A-4F79-86C0-45A1CBB28486

P2860

Inhibition of metalloprotease hyperactivity in cystic cholangiocytes halts the development of polycystic liver diseases

http://www.wikidata.org/entity/Q35185224

description

2014 nî lūn-bûn

@nan

2014 թուականի Յունուարին հրատարակուած գիտական յօդուած

@hyw

2014 թվականի հունվարին հրատարակված գիտական հոդված

@hy

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

name

Inhibition of metalloprotease ...... t of polycystic liver diseases

@ast

Inhibition of metalloprotease ...... t of polycystic liver diseases

@en

type

label

Inhibition of metalloprotease ...... t of polycystic liver diseases

@ast

Inhibition of metalloprotease ...... t of polycystic liver diseases

@en

prefLabel

Inhibition of metalloprotease ...... t of polycystic liver diseases

@ast

Inhibition of metalloprotease ...... t of polycystic liver diseases

@en

P1433

Q35185224-D035FFB1-D117-46E0-86C8-461B446FAD04

P1476

Q35185224-1BC3E97A-E7F9-4768-A9E0-195C9E9ECFD9

P2093

Q35185224-34D1BBD0-FC65-433F-AEB7-F43752CF357C

Q35185224-4661DF01-DD6D-44EC-94C2-5027D9C52162

Q35185224-5983A11A-A903-4998-9AC4-839382CC459A

Q35185224-5D1D14A2-ABAF-452B-A5AB-E1113716B845

Q35185224-69C7D6C0-51B2-4FE1-8FF3-22976E10238D

Q35185224-81944710-88C7-4481-AF79-4B5A97D31113

Q35185224-83053DD8-FA06-41C6-B6FD-AB85F22C8A56

Q35185224-9F32BE2B-2D8F-4D9C-A00F-07FC71C7963A

Q35185224-A873F147-1CDC-4ACB-9D09-9096B2DA3287

Q35185224-B510A293-A255-442C-ACA7-E420D45A5019

P2860

Q35185224-04C9C024-FF17-4B60-92AB-6A3A8702DA43

Q35185224-09B49307-EAA7-4F9C-B461-B6AEA89F3FCA

Q35185224-0A0D697F-CC1A-4A97-8763-C414EF6F553A

Q35185224-0E44B352-24F9-4960-A973-E7ADA4A87164

Q35185224-134AE025-CC99-400C-ABB1-C2C65A38E20E

Q35185224-1DEA1501-A8CE-41AB-B1E9-6A1EACD9E1D0

Q35185224-2384A3D6-81C0-4B9C-8B5B-CFC1B3517ED3

Q35185224-23B62AE5-0804-4F13-9406-EECAC4215B4A

Q35185224-309540EF-AE4E-4FBF-AF63-89ADD5DEADE8

Q35185224-31F2933B-7FAA-4729-BDB7-48CB8A1612DF

P304

Q35185224-8FDD92B9-CFE0-4477-8CAA-611378136CE1

P31

Q35185224-6B0DFD59-31F6-45A8-827F-110DEDC2902E

P356

Q35185224-8CD4ACAA-629E-4EBB-A1CB-C87691BB5791

P407

Q35185224-637BEFD6-2ABB-439B-A93D-CD833C4E7A21

P433

Q35185224-E6F9F864-F487-4105-B1F1-E62A9E644704

P478

Q35185224-EC54C87A-B9E3-4C19-8A5C-97ECDF23BEA1

P50

Q35185224-91F72754-CF86-4190-9D9F-5F343C6D3887

Q35185224-96F1E2DE-C6F9-431A-95F2-D9B5FBFBC05C

Q35185224-A4F82586-23F1-4B83-A796-742BDAB47D81

Q35185224-A6D5B73C-8213-4D66-9B53-3C4CA1FC3541

Q35185224-E8DB6E9B-64C6-4DFC-853F-5B870C95659D

P577

Q35185224-4110CE5C-4409-4F7B-B077-E45FD7CFC0C9

P5875

Q35185224-8C256229-4535-4BF9-9B38-F68F8BA60684

P698

Q35185224-48D07280-D4C1-4A59-8C49-A1064C4950C7

P932

Q35185224-952B881B-A22F-4F55-9233-2131AD67BEAD

P356

GUTJNL-2013-305281

P1433

P1476

Inhibition of metalloprotease ...... t of polycystic liver diseases

@en

P2093

Ander Arbelaiz

http://www.w3.org/2001/XMLSchema#string

Aura D Urribarri

http://www.w3.org/2001/XMLSchema#string

Elisa Lozano

http://www.w3.org/2001/XMLSchema#string

Elizabeth Hijona

http://www.w3.org/2001/XMLSchema#string

Juan P Jimeno

http://www.w3.org/2001/XMLSchema#string

Maite G Fernandez-Barrena

http://www.w3.org/2001/XMLSchema#string

Maite Merino-Azpitarte

http://www.w3.org/2001/XMLSchema#string

Marco Marzioni

http://www.w3.org/2001/XMLSchema#string

María J Perugorria

http://www.w3.org/2001/XMLSchema#string

Nicholas F LaRusso

http://www.w3.org/2001/XMLSchema#string

P2860

Molecular cloning of APRF, a novel IFN-stimulated gene factor 3 p91-related transcription factor involved in the gp130-mediated signaling pathway

Tissue inhibitors of metalloproteinases

New drugs on the horizon: matrix metalloproteinase inhibitors

Hepatic cystogenesis is associated with abnormal expression and location of ion transporters and water channels in an animal model of autosomal recessive polycystic kidney disease

Effects of angiogenic factor overexpression by human and rodent cholangiocytes in polycystic liver diseases

Matrix metalloproteinases and the regulation of tissue remodelling

Up-regulation of microRNA 506 leads to decreased Cl-/HCO3- anion exchanger 2 expression in biliary epithelium of patients with primary biliary cirrhosis.

A possible role for metalloproteinases in renal cyst development.

CXCR2 agonists in ADPKD liver cyst fluids promote cell proliferation.

The cAMP effectors Epac and protein kinase a (PKA) are involved in the hepatic cystogenesis of an animal model of autosomal recessive polycystic kidney disease (ARPKD).

P304

1658-1667

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1136/GUTJNL-2013-305281

http://www.w3.org/2001/XMLSchema#string

P407

P433

10

http://www.w3.org/2001/XMLSchema#string

P478

63

http://www.w3.org/2001/XMLSchema#string

P50

Jesus M Banales

P577

2014-01-16T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

259771106

http://www.w3.org/2001/XMLSchema#string

P698

24436140

http://www.w3.org/2001/XMLSchema#string

P932

4362729

http://www.w3.org/2001/XMLSchema#string